Company intelligence / Profile preview
Beijing Double-Crane Runchuang Technology Co., Ltd.
Beijing, Beijing, Chinadcpc.com ↗
- Ownership
- Private
- Development stage
- Commercial
01
Overview
The company is an active subsidiary focused on small molecule drug development targeting oncology, infectious diseases, and metabolic disorders. Its most advanced programs are in early clinical stages with at least one program reaching Phase I/II trials for ovarian cancer and another at IND stage for solid tumors. Published research includes novel NDM‑1 inhibitors to combat multidrug-resistant bacterial infections.
- Therapeutic areas
- OncologyEndocrinologyInfectious Diseases
- Modalities
- Small molecule drugsPotentially others (see pipeline)
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Beyond the preview
Go deeper on Beijing Double-Crane Runchuang Technology Co., Ltd..
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Beijing Double-Crane Runchuang Technology Co., Ltd..